Psycho-Babble Medication | about biological treatments | Framed
This thread | Show all | Post follow-up | Start new thread | List of forums | Search | FAQ

Re: Aripiprazole and d2 upregulation

Posted by SLS on March 26, 2002, at 19:49:46

In reply to Aripiprazole and d2 upregulation, posted by JohnX2 on March 25, 2002, at 1:55:10

> Aripiprazole, a novel antipsychotic drug, inhibits quinpirole-evoked GTPase activity but does not up-regulate dopamine D2 receptor following repeated treatment in the rat striatum.


Hi John.

This looks encouraging.

Can you find anything that makes a similar comparison to olanzapine or ziprasidone? It might help to elucidate whether or not the reduced magnitude of DA D2 receptor upregulation can be assigned to those properties of aripiprazole that Stephen Stahl characterizes as being of a DSS (dopamine system stabilizer). Aripiprazole has been described by others as being a partial DA receptor agonist.


- Scott

 

Thread

 

Post a new follow-up

Your message only Include above post


Notify the administrators

They will then review this post with the posting guidelines in mind.

To contact them about something other than this post, please use this form instead.

 

Start a new thread

 
Google
dr-bob.org www
Search options and examples
[amazon] for
in

This thread | Show all | Post follow-up | Start new thread | FAQ
Psycho-Babble Medication | Framed

poster:SLS thread:99979
URL: http://www.dr-bob.org/babble/20020322/msgs/100394.html